Logo

NIPT

Ravgen NIPT Patents Withstand Illumina Challenge

The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.

Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses
Premium

The company is planning to launch a 4-in-1 prenatal screening test, a liquid biopsy test, and a minimal residual disease assay in the coming year.

Digital PCR Startup Enumerix's Ultra-dPCR Method Massively Expands Droplet Number
Premium

The Ultra-dPCR method purports to create approximately 30 million droplets using a low-cost consumable and standard lab instruments.

ACMG Strongly Recommends NIPS for Common Trisomies for All Pregnancies

The new guidelines, based on a recent evidence review, also recommend offering NIPS for detecting fetal sex chromosome aneuploidies for singleton pregnancies.

BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPT
Premium

In a recent study, pregnancy outcomes correlated with the Unity test's fetal risk estimates for recessive conditions, and the company is now conducting further validation studies.

Dec 14, 2022

Ravgen's NIPT Patents Found Valid in Administrative Challenge

Dec 6, 2022

Cowen Upgrades PerkinElmer Stock to Outperform

Nov 28, 2022

Juno Diagnostics Lowers Barriers to Noninvasive Prenatal Testing With At-Home Sample Collection
Premium

Nov 28, 2022

ARCEDI Biotech Developing Cystic Fibrosis, Cancer Tests; Plans to Expand NIPT Offering
Premium

Nov 9, 2022

Dante Genomics, Al Farabi Medical Laboratories Partner on NGS-Based Testing in Saudi Arabia

Nov 9, 2022

Natera Raises Guidance on Test Volume Growth, Notes Reimbursement Opportunities
Premium

Oct 20, 2022

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court
Premium

Oct 11, 2022

Quest Diagnostics, Ravgen Settle Patent Infringement Suit

Sep 27, 2022

Ravgen Wins $273M Award in Patent Infringement Suit Against Labcorp

Aug 16, 2022

Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs
Premium

Aug 2, 2022

LGC Clinical Diagnostics, Stanford University Extend Collaboration for NIPT Reference Materials

Jul 14, 2022

Genetic Counseling Likely to Become More 'Complicated' in Wake of Roe Repeal 
Premium

Jun 2, 2022

Genome-Wide Noninvasive Prenatal Genetic Testing Uncovers Additional Findings Beyond Common Trisomies

May 24, 2022

ACMG Review Finds NIPS Accurately Detects Common Trisomies in General-Risk Pregnancies

May 5, 2022

Natera Q1 Revenues Rise 28 Percent on Increased Product Revenues

Apr 25, 2022

Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnership

Apr 20, 2022

FDA Cautions of False Results From Prenatal Genetic Tests

Mar 30, 2022

BillionToOne Raises $125M in Series C Funding Round

Mar 9, 2022

Natera Refutes Claims in Short Seller Report After Stock Plummets

Feb 25, 2022

Natera Hit With Multiple Class Action Suits Over 'Unreliable' NIPT Results

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.